| 张晓丹,赵红丽,李潞,周佳萌,王晓昕,王小溪.非瓣膜病房颤患者VKORC1与CYP2C9基因多态性华法林抗凝剂量模型临床疗效评价[J].中国心血管病研究,2016,14(7): |
| 非瓣膜病房颤患者VKORC1与CYP2C9基因多态性华法林抗凝剂量模型临床疗效评价 |
| Evaluation of clinical efficacy in patients with nonvalvular atrial fibrillation VKORC1 and CYP2C9 gene polymorphism warfarin anticoagulation dose modelZhang Xiao-Dan,Zhao Hong-Li, Li-Lu ,Zhou jia-meng,Wang xiao-xin,Wang xiao-xi.Department of Cardiology,the Second Affiliated Hospital of Shenyang Medical College. |
| 投稿时间：2016-01-12 修订日期：2016-04-30 |
| 关闭 |
|
|
|
